KRYSKrystal Biotech, Inc.
341.05USD-0.67%Mkt Cap: 10.16B $P/E: 42.97

Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company c…

Key Statistics

Company
Market Cap10.16B $
Enterprise Value9.14B $
Revenue (TTM)440.48M $
Gross Profit366.08M $
Net Income (TTM)204.83M $
Revenue/Share15.08 USD
Last Price341.05 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees295
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS5011471027
Valuation
P/E (Trailing)42.97
P/E (Forward)35.86
PEG
EV/EBITDA45.85
EV/Revenue20.75
P/S22.65
P/B7.34
EPS (TTM)7.97
EPS (Forward)9.40
52W Range
136.7383% of range382.54
52W High382.54 USD
52W Low136.73 USD
Profitability
Gross Margin94.08%
Oper. Margin49.00%
EBITDA Margin45.24%
Profit Margin52.64%
ROE16.80%
ROA15.36%
Growth
Revenue Growth24.10%
Earnings Growth38.80%
Cash Flow & Leverage
Operating CF200.87M $
CapEx (TTM)11.95M $
FCF Margin34.45%
FCF Yield1.49%
Net Debt-836.78M $
Net Debt/EBITDA-4.20
Balance Sheet
Debt/Equity0.01
Current Ratio8.32
Quick Ratio7.73
Book Value/Sh45.92 USD
Cash/Share28.57 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)385.00 USD
Upside (mean)+12.9%
Target Range284.00 USD474.00 USD
$284.00+12.9% to mean$474.00
# Analysts8
Ownership
Shares Out.29.60M
Float23.57M
Insiders10.83%
Institutions102.52%
Short Interest
Short Ratio5.8d
Short % Float17.72%
Short % Out.10.82%
Shares Short3.20M
Short (prev mo.)3.52M
Technical
SMA 50344.67 (-1.1%)
SMA 200281.75 (+21.0%)
Beta0.54
S&P 52W Chg18.16%
Avg Vol (30d)495.26K
Avg Vol (10d)168.83K
Technical Indicators
RSI (14)53.2
MACD-2.6058
MACD Signal-3.2099
MACD Hist.+0.6041
BB Upper365.97 USD
BB Middle336.51 USD
BB Lower307.06 USD
BB Width17.51%
ATR (14)13.58 USD
Vol Ratio (20d)0.27x